diabetes mellitus, type 2

You have accessRestricted Access
Effects of Dapagliflozin on Circulating Markers of Phosphate Homeostasis
Maarten A. de Jong, Sergei I. Petrykiv, Gozewijn D. Laverman, Antonius E. van Herwaarden, Dick de Zeeuw, Stephan J.L. Bakker, Hiddo J.L. Heerspink and Martin H. de Borst

CJASN January 2019, 14 (1) 66-73; DOI: https://doi.org/10.2215/CJN.04530418

Add to Selected Citations
You have accessRestricted Access
ACCORDION: Ensuring That We Hear the Music Clearly
Muh Geot Wong, Hiddo J.L. Heerspink and Vlado Perkovic

CJASN November 2018, 13 (11) 1621-1623; DOI: https://doi.org/10.2215/CJN.11370918

Add to Selected Citations
You have accessRestricted Access
Long-Term Effects of Intensive Glycemic and Blood Pressure Control and Fenofibrate Use on Kidney Outcomes
Amy K. Mottl, John B. Buse, Faramarz Ismail-Beigi, Ronald J. Sigal, Carolyn F. Pedley, Vasilios Papademetriou, Debra L. Simmons, Lois Katz, Josyf C. Mychaleckyj and Timothy E. Craven

CJASN November 2018, 13 (11) 1693-1702; DOI: https://doi.org/10.2215/CJN.06200518

Add to Selected Citations
You have accessRestricted Access
COL4A3 Gene Variants and Diabetic Kidney Disease in MODY
Yiting Wang, Junlin Zhang, Yingwang Zhao, Shanshan Wang, Jie Zhang, Qianqian Han, Rui Zhang, Ruikun Guo, Hanyu Li, Li Li, Tingli Wang, Xi Tang, Changzheng He, Geer Teng, Weiyue Gu and Fang Liu

CJASN August 2018, 13 (8) 1162-1171; DOI: https://doi.org/10.2215/CJN.09100817

Add to Selected Citations
You have accessRestricted Access
Incidence and Progression of Chronic Kidney Disease in Black and White Individuals with Type 2 Diabetes
Claire Gerber, Xuan Cai, Jungwha Lee, Timothy Craven, Julia Scialla, Nao Souma, Anand Srivastava, Rupal Mehta, Amanda Paluch, Alexander Hodakowski, Rebecca Frazier, Mercedes R. Carnethon, Myles Selig Wolf and Tamara Isakova

CJASN June 2018, 13 (6) 884-892; DOI: https://doi.org/10.2215/CJN.11871017

Add to Selected Citations
You have accessRestricted Access
Kidney Biomarkers and Decline in eGFR in Patients with Type 2 Diabetes
Katherine G. Garlo, William B. White, George L. Bakris, Faiez Zannad, Craig A. Wilson, Stuart Kupfer, Muthiah Vaduganathan, David A. Morrow, Christopher P. Cannon and David M. Charytan

CJASN March 2018, 13 (3) 398-405; DOI: https://doi.org/10.2215/CJN.05280517

Add to Selected Citations
You have accessRestricted Access
Hyperkalemia across the Continuum of Kidney Function
Biff F. Palmer and Deborah J. Clegg

CJASN January 2018, 13 (1) 155-157; DOI: https://doi.org/10.2215/CJN.09340817

Add to Selected Citations
You have accessRestricted Access
Is Chronic Dialysis the Right Hard Renal End Point To Evaluate Renoprotective Drug Effects?
Misghina Weldegiorgis, Dick de Zeeuw, Jamie P. Dwyer, Peter Mol and Hiddo J.L. Heerspink

CJASN October 2017, 12 (10) 1595-1600; DOI: https://doi.org/10.2215/CJN.09590916

Add to Selected Citations
You have accessRestricted Access
Soluble Urokinase Plasminogen Activator Receptor and Outcomes in Patients with Diabetes on Hemodialysis
Christiane Drechsler, Salim S. Hayek, Changli Wei, Sanja Sever, Bernd Genser, Vera Krane, Andreas Meinitzer, Winfried März, Christoph Wanner and Jochen Reiser

CJASN August 2017, 12 (8) 1265-1273; DOI: https://doi.org/10.2215/CJN.10881016

Add to Selected Citations
You have accessRestricted Access
Differential Effects of Dapagliflozin on Cardiovascular Risk Factors at Varying Degrees of Renal Function
Sergei Petrykiv, C. David Sjöström, Peter J. Greasley, John Xu, Frederik Persson and Hiddo J.L. Heerspink

CJASN May 2017, 12 (5) 751-759; DOI: https://doi.org/10.2215/CJN.10180916

Add to Selected Citations

Main menu

User menu

Search

diabetes mellitus, type 2

Pages

About

Author Information

More information